sirna experiments gene expression (Horizon Discovery)
Structured Review

Sirna Experiments Gene Expression, supplied by Horizon Discovery, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sirna experiments gene expression/product/Horizon Discovery
Average 92 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells"
Article Title: Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells
Journal: Cell Death & Disease
doi: 10.1038/s41419-019-2081-4

Figure Legend Snippet: Cisplatin induces intrinsic and ROS dependent apoptosis. a Division rate was determined by counting cells on 4 consecutive days. b , c Viable (Annexin V negative/PI negative) cells after co-incubation with b 2 mM Glutathion or c 50 µM zVAD-fmk and 10 µM cisplatin for 48 h. ( d , bottom) Western blot analysis of BAX and BAK expression in cells transfected with siRNA targeting BAX and BAK or control siRNA and ( d , top) flow cytometric analysis of viability (Annexin V negative/PI negative) after treatment with 10 µM cisplatin for 48 h. Data represent means ± SD from at least three independent experiments
Techniques Used: Incubation, Western Blot, Expressing, Transfection, Flow Cytometry

Figure Legend Snippet: Reduction of mtROS enhances survival after cisplatin treatment. a – c Flow cytometric analysis of OVCAR-3 and OVCAR-4 after co-treatment with ATP synthase inhibitor Oligomycin A (5 µM) and 10 µM cisplatin for 48 h. a Oligomycin A reduces cisplatin mediated mtROS induction (MitoSOX red) while b mitochondrial content (Mitotracker Green) is unaffected. c Oligomycin A increases viability (Annexin V negative/PI negative) after cisplatin incubation. d Western blot analysis of OVCAR-3 and OVCAR-8 cells after treatment with 10 µM cisplatin for 48 h shows increased TFAM protein expression. e – g siRNA mediated knockdown of PGC1α in OVCAR-4. e Expression of PGC1α (top) and TFAM (bottom) are decreased in transfected OVCAR-4 cells. f Flow cytometric analysis shows decreased mtROS induction (MitoSox red) in PGC1α silenced cells after treatment with 10 µM cisplatin for 48 h. g Flow cytometric analysis of cell viability (Annexin V negative/PI negative) reveals PGCA1 α knockdown mediated enhanced survival after treatment with 10 µM cisplatin for 48 h. ( h , left) siRNA mediated knockdown of TFAM in OVCAR-4 cells ( h , right) is associated with enhanced viability (Annexin V negative/PI negative) in a flow cytometric analysis after treatment with 10 µM cisplatin for 48 h. Data represent means ± SD or a representative experiment from at least three independent experiments
Techniques Used: Flow Cytometry, Incubation, Western Blot, Expressing, Transfection
Related Articles
Expressing:Article Title: Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells Article Snippet: .. |